Treatment of Binge Eating in Obese Patients in Primary Care

Completed · Phase 4 · Has a placebo group

Conditions studied: Obesity, Binge Eating

In brief

This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.

Key facts

Study ID

NCT00537810

Run by

Yale University

People needed

104

Starts

2007-09-01

Expected to finish

2012-10-01

Last updated by the study team

2021-08-18

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Obese (BMI >= 30)

You may not qualify if…

• Medication regimen that represents medical contraindication to sibutramine
• Serious unstable or uncontrolled medical conditions that represent contraindication to sibutramine
• Pregnancy

Where it is running

• Yale Internal Medicine Associates (YIMA) — New Haven, Connecticut, United States
• Yale-New Haven Hospital (YNHH) Primary Care Center (PCC) — New Haven, Connecticut, United States
• Yale Psychiatric Research at Congress Place — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.